Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 6/20 | 0.35 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.35 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 3/20 | 0.34 |
| ▸ | AGER | Q15109 | 2/20 | 0.33 |
| ▸ | PDE5A | O76074 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710259 | 0.93 | BRD4 (0.36) | SMN1; SMN2HSD17B10LMNAMAPTBRD4 | |
| SCHEMBL6708800 | 0.93 | KDM1A (0.34) | SMN1; SMN2HSD17B10LMNAMAPTBRD4 | |
| SCHEMBL6710416 | 0.91 | BRD4 (0.32) | SMN1; SMN2HSD17B10LMNAMAPTBRD4 | |
| SCHEMBL6710086 | 0.89 | MET (0.38) | LMNAMAPTRXFP1 | |
| SCHEMBL6710036 | 0.89 | KDM1A (0.39) | BRD4CNR2PPARG | |
| SCHEMBL6712425 | 0.89 | TP53 (0.38) | TP53TSHRPLA2G2ASMN1; SMN2LMNA | |
| SCHEMBL6709189 | 0.89 | GRIK1 (0.39) | TP53TSHRLMNAMAPTRXFP1 | |
| SCHEMBL6707891 | 0.89 | HSD17B10 (0.33) | TP53TSHRSMN1; SMN2HSD17B10LMNA | |
| SCHEMBL6707657 | 0.88 | ALK (0.40) | SMN1; SMN2HSD17B10LMNAMAPTRXFP1 | |
| SCHEMBL6707654 | 0.88 | ALK (0.40) | SMN1; SMN2HSD17B10LMNAMAPTRXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | TP53 2699/4885TSHR 3901/4885PLA2G2A 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.